The Effect of Intraportal Prostaglandin E1 on Adhesion Molecule Expression, Inflammatory Modulator Function, and Histology in Canine Hepatic Ischemia/Reperfusion Injury

BackgroundProstaglandin E1 (PGE1) is known to protect the liver from I/R, however, the mechanism of cytoprotection is not well understood. This study investigates the effect of intraportal infusion of PGE1 in a warm liver ischemia/reperfusion (I/R) model on cytokines, adhesion molecules and liver structure.Materials and methodsTwenty dogs underwent laparotomy under general anesthesia. PGE1 (0.02 μg\kg\min) was perfused through the portal vein in the PGE1 group (n = 10), or a similar volume of Ringer’s solution in the control group (n = 10) for 15 min. Liver ischemia was induced by hepatic artery and portal vein occlusion and PGE1 was infused via the portal vein for 60 min. The occlusion was released and PGE1 infusion recommenced for 30 min. Blood and liver biopsies were sampled at baseline, 60 min ischemia, and 30 min reperfusion and assessed for transaminases, cytokines, adhesion molecules, and electron microscopy.ResultsPGE1 infusion significantly reduced transaminases TNF-α, sICAM-1, sP-selectin, and sE-selectin on ischemia and reperfusion. PGE1 reduced hepatocytic degeneration, portal and central ICAM-1 expression, central and sinusoidal VCAM-1 expression, portal and central P-selectin expression, and portal and sinusoidal E-selectin expression on reperfusion.ConclusionIntraportal PGE1 infusion reduced I/R injury and was associated with down-regulation of ICAM-1, VCAM-1, P-selectin, and E-selectin on reperfusion.